Bookbuilding IPO | ₹98 Cr | Listed at BSE, NSE | Mon, Feb 5, 2007 - Thu, Feb 8, 2007
SMS Pharmaceuticals IPO is a book build issue of ₹98.01 crores. The issue is entirely a fresh issue of 0.26 crore shares of ₹98.01 crore.
SMS Pharmaceuticals IPO bidding started from Feb 5, 2007 and ended on Feb 8, 2007. The shares got listed on BSE, NSE on Feb 28, 2007.
SMS Pharmaceuticals IPO price band is set at ₹380 per share. The lot size for an application is 15. The minimum amount of investment required by an retail is ₹5,700 (15 shares) (based on upper price). The lot size investment for sNII is 36 lots (540 shares), amounting to ₹2,05,200, and for bNII, it is 176 lots (2,640 shares), amounting to ₹10,03,200.
UTI Securities Ltd. is the book running lead manager and Aarthi Consultants Pvt.Ltd. is the registrar of the issue.
Refer to SMS Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Mon, Feb 5, 2007
IPO Close
Thu, Feb 8, 2007
Issue Price
₹380 per share
Market Cap (Pre-IPO)
₹380.00 Cr
| IPO Date | 5 to 8 Feb, 2007 |
| Listed on | Wed, Feb 28, 2007 |
| Face Value | ₹10 per share |
| Price Band | ₹360 to ₹380 |
| Issue Price | ₹380 per share |
| Lot Size | 15 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 25,79,225 shares (agg. up to ₹98 Cr) |
| Fresh Issue | 25,79,225 shares (agg. up to ₹98 Cr) |
| Share Holding Pre Issue | 74,23,000 shares |
| Share Holding Post Issue | 1,00,00,000 shares |
| BSE Script Code / NSE Symbol | 532815 / SMSPHARMA |
| ISIN | INE812G01025 |
SMS Pharmaceuticals IPO comprises a total issue size of 25,77,000 shares. Out of which, 12,88,500 (50.00%) are allocated to QIB, 3,86,550 (15.00%) allocated to NII 9,01,950 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 12,88,500 | 50.00% | NA |
| NII (HNI) Shares Offered | 3,86,550 | 15.00% | NA |
| Retail Shares Offered | 9,01,950 | 35.00% | 60,130 |
| Total Shares Offered | 25,77,000 | 100.00% |
Investors can bid for a minimum of 15 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹5,700 |
| Retail (Max) | 35 | 525 | ₹1,99,500 |
| S-HNI (Min) | 36 | 540 | ₹2,05,200 |
| S-HNI (Max) | 175 | 2,625 | ₹9,97,500 |
| B-HNI (Min) | 176 | 2,640 | ₹10,03,200 |
SMS Pharmaceuticals Limited is leading manufacturers and exporters of Active Pharmacy Ingredients and pharmaceutical intermediates in India, commonly known as Bulk Drug Manufacturer.
SMS Pharma is mainly engaged in manufacturing bulk drugs like Ranitidine HCl, Sumatriptan Succinate, Sildenofil Citrate, Omeprazole Magnesium, Ramipril, Almotriptan maleate, Gemcitabine HCl, Imatinib Mesilate and their intermediates.
SMS Pharma has an integrated manufacturing facility, professional skilled workforce, R&D expertise and an ever-expanding array of API's and Bulk Intermediates.
SMS Pharma operates through three manufacturing units, one pilot plant and one basic research facility in and around Hyderabad.
Other Group Companies/Promoter's Ventures:
1. Bhagyanagar Castings Limited
2. Web City Softech Private Limited
3. Hima Farms Private Limited
4. Potluri Real Estate Private Limited
5. Potluri Builders Private Limited.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of facilities for manufacturing Active Pharmaceuticals Ingredients (APIs) at Kandivalsa Village, Vizianagaram District, Andhra Pradesh | 113.02 |
| 2 | Net Working Capital | |
| 3 | Public Issue Expenses & Others |
| KPI | |
|---|---|
| RoNW | 17.41% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 72.31% | 53.68% |
| Market Cap | ₹380.00 Cr. |
The SMS Pharmaceuticals IPO is subscribed 2.64 times on February 8, 2007 5:00:00 PM (Day 4). The public issue subscribed 2.47 times in the retail category, 3.47 times in the QIB category, and 0.28 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹380.00 | ₹380.00 |
| Open | ₹349.90 | ₹360.00 |
| Low | ₹285.30 | ₹250.00 |
| High | ₹390.00 | ₹388.60 |
| Last Trade | ₹357.85 | ₹359.25 |
Lead Manager Reports
SMS Pharmaceuticals IPO is a main-board IPO of 25,79,225 equity shares of the face value of ₹10 aggregating up to ₹98 Crores. The issue is priced at ₹380 per share. The minimum order quantity is 15.
The IPO opens on Mon, Feb 5, 2007, and closes on Thu, Feb 8, 2007.
Aarthi Consultants Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in SMS Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in SMS Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in SMS Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The SMS Pharmaceuticals IPO opens on Mon, Feb 5, 2007 and closes on Thu, Feb 8, 2007.
SMS Pharmaceuticals IPO lot size is 15, and the minimum amount required for application is ₹5,700.
You can apply in SMS Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for SMS Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the SMS Pharmaceuticals IPO allotment status.
The SMS Pharmaceuticals IPO listing date is on Wed, Feb 28, 2007.
